T/LTIA 28-2024 Active Group standards

T/LTIA 28-2024 Guidance for ESG Evaluation of Medical Device Companies

Publish Date: 2024-11-30 Implement Date: 2024-12-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/LTIA 28-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical devices

ICS Name: Comprehensive quality

Publish Date: 2024-11-30

Implement Date: 2024-12-01

Scope

Scope: This document specifies the terms and definitions, evaluation requirements, evaluation process, evaluation report preparation, and evaluation criteria for the environmental, social, and corporate governance (ESG) evaluation of medical device manufacturing enterprises. This document is applicable to the evaluation of the current ESG governance status of medical device manufacturing enterprises. Main technical content: This guide aims to provide medical device enterprises with a comprehensive, systematic, and actionable ESG evaluation framework. Through this framework, enterprises can: 1) Define the objectives and principles of ESG evaluation: Build a logically sound evaluation system around the enterprise's sustainable development capabilities to ensure the systematization, completeness, and practicality of the evaluation. 2) Evaluation content and methods: The evaluation content covers three main modules: environment, society, and governance. Each module sets up secondary and tertiary indicators to comprehensively reflect the key aspects of the enterprise's ESG. 3) Evaluation organization and calculation methods: The evaluation organization is responsible for evaluating the processed and analyzed information. Through the measurement scope of quantitative indicators and the evaluation scope of qualitative indicators, the total ESG score of the enterprise is calculated.